Safety and Clinical Activity of Medi5752, a Pd-1/Ctla-4 Bispecific Checkpoint Inhibitor, as Monotherapy in Patients (Pts) with Advanced Renal Cell Carcinoma (Rcc): Preliminary Results from an Ftih Trial.

AuthID
 P-00X-EB0
19
Author(s)
Rodriguez, LM
·
Kim, SW
·
Im, SA
·
Carcereny, E
·
Rha, SY
·
Tran, B
·
Oliveira, J
·
Maroto-Rey, P
·
Su, WC
·
Voskoboynik, M
·
Rodriguez-Vida, A
·
Costa, L
·
Ascierto, PA
·
Molla, MAI
·
Wang, Y
·
Gainer, SD
·
Subramaniam, DS
·
Voss, MH
Document Type
Abstract
Year published
2022
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 40, Issue: 16
Indexing
Wos®
Publication Identifiers
Wos: WOS:000863680300241
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service